...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019

Koo, 

I am cautiously optimistic that is the case. Processes such as trigylceride level decrease, membrane stabilisation, anithrombotic activity that are being labelled separate mechanisms are part of the cellular inflammation process  and I believe the RVX drug does impact inflammation through all these  individual processes.

Share
New Message
Please login to post a reply